Cover image of the article: Prevalence and Risk Factors of Hepatitis B Infection in Injection Drug Users, Tehran (2001-2002)

Image Credit:Hepat Mon

Prevalence and Risk Factors of Hepatitis B Infection in Injection Drug Users, Tehran (2001-2002)

Authors

Hamid Tavakkoli1,*, Mohammad Mahdi Mir-Nasseri2, Hossein Poustchi2, Parviz Afshar2, Mohammad Nabi Motalebi2, Ashraf Mohammadkhani2, Reza Malekzadeh2
1Assistant Professor of Gastroenterology, Al-Zahra University Hospital, Department of Gastroenterology, Isfahan University of Medical Sciences, h_tavakoli@med.mui.ac.ir, IR-Iran
2Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, IR-Iran
*Corresponding Author: Assistant Professor of Gastroenterology, Al-Zahra University Hospital, Department of Gastroenterology, Isfahan University of Medical Sciences, h_tavakoli@med.mui.ac.ir, IR-Iran. Tel: +98 311 6255555. Email: h_tavakoli@med.mui.ac.ir

Hepatitis Monthly:Vol. 8, issue 1; 29-33
Published online:Mar 31, 2008
Article type:Research Article
Received:Dec 18, 2007
Accepted:Apr 13, 2008
How to Cite:Tavakkoli H, Mir-Nasseri M, Poustchi H, Afshar P, Motalebi M, et al. Prevalence and Risk Factors of Hepatitis B Infection in Injection Drug Users, Tehran (2001-2002). Hepat Mon. 2008;8(1):. doi:

Abstract

Background and Aims: Hepatitis B virus (HBV) infection has a high incidence among injection drug users (IDUs). Several important behavioral risk factors influence transmission of HBV in this group. However, consensus has not been achieved on many of them. The aim of this investigation was to assess the prevalence and risk factors for HBV in IDUs.
Methods: This cross-sectional study was carried out between 2001 and 2002 in Tehran. IDUs included people who were being treated for drug abuse and those in the prison. Physician-completed risk factor questionnaires and blood samples (5 ml) for serologic HBV markers (ELISA) were used. Risk factors were evaluated in binary logistic regression (LR) model (forward) procedure for possible association with odds of past or current HBV infection. The evaluated risk factors were age, gender, sexual behavior, shared syringe use, duration of addiction, imprisonment, tattooing, past history of surgery, dental procedures, blood transfusion, jaundice, type of illicit drug use and level of education.
Results:  This study sample was comprised of 518 IDUs (89.6% males), including 386 (74.5%) prisoners. Antibody against HBV core antigen (HBcAb) was detected in 61.2% (n=317). The prevalence of hepatitis B surface antigen (HBsAg) was 3.7% (n=19). Among HBsAg positive patients, HBeAg was positive in 12 individuals (63.2%). In comparison with seronegative IDUs for HBcAb and/or HBsAg, the odds of using shared syringes, male sex and past history of bisexual relationship were 1.5 (P<0.05), 1.9 (P<0.05) and 2.4 (P<0.01), respectively.
Conclusions: These results suggest that seroprevalence of hepatitis B is high but chronic carrier state is not frequent in IDUs. Imprisonment, male sex and having past history of bisexual relationship are independent risk factors for past or current hepatitis B infection.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2008, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Dec
2011
Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran

Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran

Masoumeh Amin-Esmaeili,
Masoumeh Amin-Esmaeili,
Afarin Rahimi-Movaghar,
Afarin Rahimi-Movaghar,
Emran M. Razaghi,
Emran M. Razaghi
,et al.

Amin-Esmaeili M, Amin-Esmaeili M, Rahimi-Movaghar A, Rahimi-Movaghar A, Razaghi E, et al. Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran. Hepat Mon. 2011;12(1):. doi: https://doi.org/10.5812/kowsar.1735143X.806

30
Jun
2010
Seroprevalence Study of Hepatitis C and Hepatitis B Virus among Hospitalized Intravenous Drug Users in Ahvaz, Iran (2002-2006)

Seroprevalence Study of Hepatitis C and Hepatitis B Virus among Hospitalized Intravenous Drug Users in Ahvaz, Iran (2002-2006)

Seyed Mohammad Alavi,
Fatemeh Behdad

Alavi S, Behdad F. Seroprevalence Study of Hepatitis C and Hepatitis B Virus among Hospitalized Intravenous Drug Users in Ahvaz, Iran (2002-2006). Hepat Mon. 2010;10(2):. doi:

29
Mar
2016
Characterization of Occult Hepatitis B Infection Among Injecting Drug Users in Tehran, Iran

Characterization of Occult Hepatitis B Infection Among Injecting Drug Users in Tehran, Iran

Maryam Asli,
Tahmineh Kandelouei,
Koroush Rahimyan,
Foad Davoodbeglou,
Maryam Vaezjalali

Asli M, Kandelouei T, Rahimyan K, Davoodbeglou F, Vaezjalali M. Characterization of Occult Hepatitis B Infection Among Injecting Drug Users in Tehran, Iran. Hepat Mon. 2016;16(3):e34763. doi: https://doi.org/10.5812/hepatmon.34763

17
Apr
2013
Reduction in Prevalence of Hepatitis B Surface Antigen Among Intravenous Drug Users in Tehran Drop-in-Centers

Reduction in Prevalence of Hepatitis B Surface Antigen Among Intravenous Drug Users in Tehran Drop-in-Centers

Tahmineh kandelouei,
Seyed Masoud Hosseini,
Latif Gachkar,
Hossein Keyvani,
Foad Davoodbeglou,
Maryam Vaezjalali

kandelouei T, Hosseini SM, Gachkar L, Keyvani H, Davoodbeglou F, et al. Reduction in Prevalence of Hepatitis B Surface Antigen Among Intravenous Drug Users in Tehran Drop-in-Centers. Arch Clin Infect Dis. 2013;8(2):e15531. doi: https://doi.org/10.5812/archcid.15531

25
Oct
2017
Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran

Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran

Asaad Sharhani,
Yadollah Mehrabi,
Alireza Noroozi,
Maryam Nasirian,
Peter Higgs,
Ahmad Hajebi
,et al.

Sharhani A, Mehrabi Y, Noroozi A, Nasirian M, Higgs P, et al. Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran. Hepat Mon. 2017;17(10):e58739. doi: https://doi.org/10.5812/hepatmon.58739

More by these authors

Hamid TavakkoliPubMedScholar
Mohammad Mir-NasseriPubMedScholar
Hossein PoustchiPubMedScholar
Parviz AfsharPubMedScholar
Mohammad MotalebiPubMedScholar
Ashraf MohammadkhaniPubMedScholar
Reza MalekzadehPubMedScholar
Share
Cited by
Metrics